345 related articles for article (PubMed ID: 30611663)
1. mRNA-Based Protein Replacement Therapy for the Heart.
Magadum A; Kaur K; Zangi L
Mol Ther; 2019 Apr; 27(4):785-793. PubMed ID: 30611663
[TBL] [Abstract][Full Text] [Related]
2. Potential Application of Modified mRNA in Cardiac Regeneration.
Wang AYL; Chang YC; Chen KH; Loh CYY
Cell Transplant; 2024; 33():9636897241248956. PubMed ID: 38715279
[TBL] [Abstract][Full Text] [Related]
3. Modified mRNA as a Treatment for Myocardial Infarction.
Wang Y; Wu M; Guo H
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902165
[TBL] [Abstract][Full Text] [Related]
4. Direct reprogramming induces vascular regeneration post muscle ischemic injury.
Kaur K; Hadas Y; Kurian AA; Żak MM; Yoo J; Mahmood A; Girard H; Komargodski R; Io T; Santini MP; Sultana N; Sharkar MTK; Magadum A; Fargnoli A; Yoon S; Chepurko E; Chepurko V; Eliyahu E; Pinto D; Lebeche D; Kovacic JC; Hajjar RJ; Rafii S; Zangi L
Mol Ther; 2021 Oct; 29(10):3042-3058. PubMed ID: 34332145
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Synthesis of Modified RNA for Cardiac Gene Therapy.
Sultana N; Sharkar MTK; Hadas Y; Chepurko E; Zangi L
Methods Mol Biol; 2021; 2158():281-294. PubMed ID: 32857381
[TBL] [Abstract][Full Text] [Related]
6. Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.
Huang CL; Leblond AL; Turner EC; Kumar AH; Martin K; Whelan D; O'Sullivan DM; Caplice NM
Mol Pharm; 2015 Mar; 12(3):991-6. PubMed ID: 25588055
[TBL] [Abstract][Full Text] [Related]
7. Modified mRNA as a Therapeutic Tool for the Heart.
Kaur K; Zangi L
Cardiovasc Drugs Ther; 2020 Dec; 34(6):871-880. PubMed ID: 32822006
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs in endothelial cell signalling and hypoxia during cardiac regeneration.
Peters MMC; Sampaio-Pinto V; da Costa Martins PA
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118515. PubMed ID: 31362011
[TBL] [Abstract][Full Text] [Related]
9. Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease.
Hadas Y; Katz MG; Bridges CR; Zangi L
Wiley Interdiscip Rev Syst Biol Med; 2017 Jan; 9(1):. PubMed ID: 27911047
[TBL] [Abstract][Full Text] [Related]
10. Delivery of Modified mRNA in a Myocardial Infarction Mouse Model.
Kaur K; Sultana N; Hadas Y; Magadum A; Sharkar MTK; Chepurko E; Zangi L
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597835
[TBL] [Abstract][Full Text] [Related]
11. Modified mRNA Therapeutics for Heart Diseases.
Magadum A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555159
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Synthesis of Modified mRNA.
Yoo J; Zangi L
Methods Mol Biol; 2022; 2573():77-87. PubMed ID: 36040588
[TBL] [Abstract][Full Text] [Related]
13. Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration.
Labonia MCI; Estapé Senti M; van der Kraak PH; Brans MAD; Dokter I; Streef TJ; Smits AM; Deshantri AK; de Jager SCA; Schiffelers RM; Sluijter JPG; Vader P
J Control Release; 2024 May; 369():734-745. PubMed ID: 38604385
[TBL] [Abstract][Full Text] [Related]
14. Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction.
Lesizza P; Prosdocimo G; Martinelli V; Sinagra G; Zacchigna S; Giacca M
Circ Res; 2017 Apr; 120(8):1298-1304. PubMed ID: 28077443
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Cardiac Delivery of Modified mRNA.
Sultana N; Magadum A; Hadas Y; Kondrat J; Singh N; Youssef E; Calderon D; Chepurko E; Dubois N; Hajjar RJ; Zangi L
Mol Ther; 2017 Jun; 25(6):1306-1315. PubMed ID: 28389322
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms Underlying Cardiomyocyte Development: Can We Exploit Them to Regenerate the Heart?
Maldonado-Velez G; Firulli AB
Curr Cardiol Rep; 2021 Jun; 23(7):81. PubMed ID: 34081213
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.
Xiang FL; Guo M; Yutzey KE
Circulation; 2016 Mar; 133(11):1081-92. PubMed ID: 26841808
[TBL] [Abstract][Full Text] [Related]
18. Large Animal Models of Cell-Free Cardiac Regeneration.
Spannbauer A; Mester-Tonczar J; Traxler D; Kastner N; Zlabinger K; Hašimbegović E; Riesenhuber M; Pavo N; Goliasch G; Gyöngyösi M
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33003617
[TBL] [Abstract][Full Text] [Related]
19. [Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].
Centola M; Schuleri KH; Lardo AC; Hare JM
G Ital Cardiol (Rome); 2008 Apr; 9(4):234-50. PubMed ID: 18543793
[TBL] [Abstract][Full Text] [Related]
20. Cardiac regeneration: the gene therapy approach.
Laguens RP; Crottogini AJ
Expert Opin Biol Ther; 2009 Apr; 9(4):411-25. PubMed ID: 19344279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]